|
|
| | Copanlisib Basic information |
| Product Name: | Copanlisib | | Synonyms: | Copanlisib HCl;copanlisib hydrochloride;Copanlisib HCI;2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide;Copanlisib.2HCl;COPANLISIB HCL; COPANLISIB DIHYDROCHLORIDE; BAY 80-6946; BAY80-6946; BAY-80-6946; BAY806946; BAY-806946; BAY 806946; COPANLISIB; TRADE NAME ALIQOPA.;trade name Aliqopa.;BAY 80-6946 dihydrochloride | | CAS: | 1402152-13-9 | | MF: | C23H29ClN8O4 | | MW: | 516.99 | | EINECS: | | | Product Categories: | | | Mol File: | 1402152-13-9.mol |  |
| | Copanlisib Chemical Properties |
| solubility | DMSO:1.0(Max Conc. mg/mL);2.08(Max Conc. mM)
Water:0.67(Max Conc. mg/mL);1.39(Max Conc. mM) | | form | Solid | | color | Off-white to light yellow |
| | Copanlisib Usage And Synthesis |
| Definition | ChEBI: Copanlisib dihydrochloride is the dihydrochloride salt of copanlisib. It has a role as an antineoplastic agent, an apoptosis inducer and an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It contains a copanlisib. |
| | Copanlisib Preparation Products And Raw materials |
|